Background Atrial fibrillation (AF) in the elderly is a complex condition. It has a direct impact
on the underuse of antithrombotic therapy reported in this population. Discussion All patients …

The last ten years have seen rapid strides in the evolution of nonvitamin K oral
anticoagulants (NOACs) for stroke prevention in patients with atrial fibrillation (AF). For the …

The purpose of this European Heart Rhythm (EHRA) Scientific Initiatives Committee EP Wire
Survey was to assess 'real-world'practice in the management of patients with atrial fibrillation …

Фибрилляция предсердий (ФП)-одна из самых распространенных аритмий. У
пациентов с ФП увеличивается риск возникновения инсульта в 5 раз, при этом …

Objective: In light of the increasing clinical utilization of the direct oral anticoagulants
(DOACs) among patients with non-valvular atrial fibrillation, this review evaluates strategies …

Randomized controlled trials are performed with a highly selected population, with good
adherence. In addition, patients with comorbidities are generally excluded and the study is …

Выбор антикоагулянта у больных с фибрилляцией предсердий, подвергаемых
кардиоверсии – тема научной статьи по клинической медицине читайте бесплатно …

Non-antivitamin K oral anticoagulants (NOACs) have recently emerged as a new class of
antithrombotic drugs. Four large-scale, randomised controlled trials (RCT) accredited …

Atrial fibrillation (AF) is the commonest cardiac arrhythmia and represents a global
healthcare problem. 1 The main priority in AF management is stroke prevention, 2 and …

Selecting a Direct Oral Anticoagulant for the Geriatric Patient with Nonvalvular Atrial Fibrillation
| Journal of Clinical Outcomes Management Skip to main content Home Journal of Clinical …